HK Stock MarketDetailed Quotes

06996 ANTENGENE-B

Watchlist
  • 1.000
  • -0.010-0.99%
Market Closed Mar 28 16:08 CST
674.89MMarket Cap-1052P/E (TTM)

About ANTENGENE-B Company

Deqi Pharmaceutical is a leading biopharmaceutical company focused on innovative anti-tumor drugs. Our uniqueness stems from our industry-leading R&D capabilities and differentiated strategic approach to developing new anti-tumor therapies. Our vision is to discover, develop and commercialize the world's first of its kind, the only treatment of its kind, and/or the best of its kind to treat patients without borders and improve their standard of living. Through effective use of resources, outstanding ability in target selection, and differentiated R&D strategies, Deqi Pharmaceutical has established a strong and highly collaborative R&D pipeline composed of 12 products, including two late-stage clinical assets and four early clinical assets. Additionally, we are developing six pre-clinical drugs that focus on innovative targets or mechanisms of action and have the potential to become number one in their class to address huge unmet medical needs. Furthermore, these drugs target key pathways of carcinogenesis and have the potential to be used in combination with each other. Since our establishment, we have established a solid R&D structure in the Asia Pacific region and have clinical research and development capabilities across the Asia Pacific region. At this stage, we are setting up a commercialization team in the Asia Pacific region to support recent product launches. The commercialization team consists of multinational company leaders with extensive commercial experience and senior practitioners with a deep understanding of the dynamics of various local markets.

Company Profile

Symbol06996
Company NameANTENGENE-B
ISINKYG039571008
Listing Date11/20/2020
Issue Price18.08
Shares Offered154.15M share
Founded08/28/2018
RegistrationCayman Islands
ChairmanJianming Mei
SecretaryYang\huangweichao Cao
Audit InstitutionErnst & Young
Company CategoryOther
Registered OfficeMaples Corporate Services Limited Office PO Box 309, Ugland House Grand Cayman, KY1-1104 Cayman Islands
Head Office and Principal Place of BusinessRoom 901, 9th floor, Nan Fung Building, 88 Connaught Road Central and 173 Des Voeux Road Central, Hong Kong
Fiscal Year Ends12-31
Employees201
MarketHong Kong motherboard
Phone(8621)23566665
Fax(8621)23561052
Emailir@antengene.com
Business Deqi Pharmaceutical Co., Ltd. is an Asia-Pacific clinical-stage biopharmaceutical company focused on innovative anti-tumor drugs. The company is mainly engaged in the discovery, development, production and commercialization of biotechnology products. The company's main products include ATG-010 (selinexor) for the treatment of recurrent/refractory multiple myeloma, recurrent/refractory large B-cell lymphoma and non-small cell lung cancer, and ATG-008 (onatasertib) for various indications such as hepatocellular carcinoma and non-small cell lung cancer. The company mainly operates in the Asia Pacific region.

Company Executives

  • Name
  • Position
  • Salary
  • Jianming Mei
  • Nomination Committee Chairman,CEO,Chairman,Remuneration Committee Member,Executive Director,Authorized Representative
  • --
  • John F. Chin
  • Chief Commercial Officer,Executive Director
  • --
  • Kan Chen
  • Non-Executive Director
  • --
  • Jing Qian
  • Nomination Committee Member,Independent Non-Executive Director,Audit Committee Member,Remuneration Committee Chairman
  • --
  • Rafael Fonseca
  • Nomination Committee Member,Independent Non-Executive Director,Audit Committee Member
  • --
  • Cheng Tang
  • Audit Committee Chairman,Remuneration Committee Member,Independent Non-Executive Director
  • --
  • Xiaojing Zhang
  • Chief Medical Officer
  • --
  • Bo Dan
  • Chief Scientific Officer
  • --
  • Zhenguo Long
  • Executive Director,Authorized Representative,CFO
  • --
  • Weichao Huang
  • Joint Company Secretary
  • --
  • Yang Cao
  • Joint Company Secretary
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg